Coupang had a rough January, losing 29% of its value. So far in February, CPNG stock has had an up-and-down month. Has it bottomed out? More
Articles
A Buyout May Be the Best Hope for Clover Health Now
The situation behind CLOV stock is spiraling from bad to worse. A sale of the company may be the only option to keep Clover Health running. More
LCID Still Has More Downside Left
LCID stock is still fully valued here (and more) but the fact is, it's well set up for the long term, if it can survive intermediate term. More
ShiftPixy Is Giving Itself Many Ways to Win by Diversifying Its Business
As ShiftPixy expands far beyond workforce management, PIXY stock offers exposure to a surprisingly diverse range of business concepts. More
Knightscope Is a Risky but Promising Addition to Your Tech-IPO Portfolio
KSCP stock soared and fell after its debut. Still, if you can handle the volatility, the stock could be a worthy security-robot investment. More
Solana Looks to Bounce Back After Dreadful January
Solana has built one of crypto's most successful and useful platforms. But it must fix its network stability issues before it's too late. More
